Flerie

Flerie is a Stockholm-based life science investment company that manages a diverse portfolio of over 30 companies across the product and service sectors. Founded by Thomas Eldered, the co-founder of the CDMO Recipharm, the firm provides long-term capital and active partnership to businesses ranging from early-stage drug developers to established manufacturing organizations. Flerie's strategic focus includes biotechnology, medical technology, and pharmaceutical services, with a particular emphasis on the Nordic region and international growth. The company is publicly traded on Nasdaq Stockholm and aims to bridge the gap between scientific innovation and commercial success. Its portfolio includes significant holdings in companies like NorthX Biologics, Xspray Pharma, and Toleranzia.